搜尋結果
2023
Yang, S. J. ,
Pai, J. A. ,
Yao, C. J. ,
Huang, C. H. ,
Chen, J. LY. ,
Wang, C. H. ,
Chen, K. C. &
Shieh, M. J. ,
12月 2023 ,
於: Cancer Nanotechnology. 14 ,
1 , 1.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Chemoradiotherapy
100%
Medical nanotechnology
83%
Hyaluronic acid
70%
Nanomedicine
61%
Hyaluronic Acid
55%
2022
Yao, C. J. ,
Yang, S. J. ,
Huang, C. H. ,
Chang, Y. T. ,
Wang, C. H. ,
Shieh, M. J. &
Young, T. H. ,
10月 2022 ,
於: Pharmaceutics. 14 ,
10 , 2117.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Amoxicillin
100%
Helicobacter pylori
73%
Retention Time
68%
Nanoparticles
67%
Anti-Bacterial Agents
49%
2017
Shih, Y. H. ,
Luo, T. Y. ,
Chiang, P. F. ,
Yao, C. J. ,
Lin, W. J. ,
Peng, C. L. &
Shieh, M. J. ,
7月 28 2017 ,
於: Journal of Controlled Release. 258 ,
p. 196-207 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
2-(2-(2-chloro-3-((1,3-dihydro-3,3-dimethyl-1-propyl-2H-indol-2-ylidene)ethylidene)-1-cyclohexen-1-yl)ethenyl)-3,3-dimethyl-1-propylindolium
100%
Micelles
60%
ErbB Receptors
47%
Cetuximab
44%
Coloring Agents
41%
2016
Lee, S. Y. ,
Yang, C. Y. ,
Peng, C. L. ,
Wei, M. F. ,
Chen, K. C. ,
Yao, C. J. &
Shieh, M. J. ,
4月 1 2016 ,
於: Biomaterials. 86 ,
p. 92-105 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Theranostics
100%
SN-38
82%
Intercellular Signaling Peptides and Proteins
77%
Small Interfering RNA
71%
Theranostic Nanomedicine
67%
2015
Shih, Y. H. ,
Peng, C. L. ,
Lee, S. Y. ,
Chiang, P. F. ,
Yao, C. J. ,
Lin, W. J. ,
Luo, T. Y. &
Shieh, M. J. ,
2015 ,
於: Oncotarget. 6 ,
18 ,
p. 16601-16610 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Cetuximab
100%
ErbB Receptors
75%
Colorectal Neoplasms
63%
Single Photon Emission Computed Tomography Computed Tomography
52%
Pentetic Acid
34%
Tsai, M. H. ,
Peng, C. L. ,
Yao, C. J. &
Shieh, M. J. ,
2015 ,
於: RSC Advances. 5 ,
112 ,
p. 92361-92370 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Micelles
100%
Ligands
88%
Antineoplastic Agent
58%
Oncology
53%
Micelle
43%
2014
Wei, M. F. ,
Chen, M. W. ,
Chen, K. C. ,
Lou, P. J. ,
Lin, S. Y. F. ,
Hung, S. C. ,
Hsiao, M. ,
Yao, C. J. &
Shieh, M. J. ,
7月 2014 ,
於: Autophagy. 10 ,
7 ,
p. 1179-1192 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Photochemotherapy
100%
Neoplastic Stem Cells
98%
Autophagy
88%
Colorectal Neoplasms
73%
Apoptosis
56%